Back in 2010 VitaminDWiki noticed that about 1/3 of the women in a study were able to greatly lose weight by just taking vitamin D: no exercise nor calorie restriction required. Had wondered why. It appears that that the women who lost weight may have had one or two flawed FTO genes
Table of contents
Diabetes Volume 63, February 2014 Corinne D. Engelman email@example.com
Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
According to the World Health Organization, the worldwide prevalence of childhood overweight and obesity increased from 4.2% in 1990 to 6.7% in 2010 and it is expected to reach 9.1% in 2020 (1). This is alarming because BMI in childhood is associated with type 2 diabetes, hypertension, coronary heart disease, and mortality in adulthood (2). The obesity epidemic is no longer merely a problem in developed countries, but is now affecting developing countries as well. In fact, more than 30 million overweight children are living in developing countries compared with 10 million in developed countries (3). In the U.S., the Surgeon General issued the Call to Action to Prevent and Decrease Overweight and Obesity (4) in 2001 and the reduction of overweight and obesity was an objective of Healthy People 2010 (5). However, the ensuing public health efforts to address the obesity epidemic by promoting healthy eating and physical activity have had limited success thus far, with overweight and obesity rates continuing to increase. At the population level, the rise in overweight and obesity rates over the past few decades has been driven by shifts in the environment, such as the abundance of food (especially fast food and junk food), increasing portion sizes, city planning that promotes transportation by automobile versus walking or biking, and growth in technology that has led to increases in screen time. On an individual level, genetic factors contribute to obesity susceptibility. The strongest genetic risk factor identified thus far is the fat mass and obesity-associated gene (FTO). Interactions between behavioral and genetic factors may play an important role in obesity risk. These interactions can be capitalized to personalize medical practice.
In the current issue, Lourenco et al. (6) assessed the effect of FTO single nucleotide polymorphism (SNP) rs9939609 on changes in BMI during childhood in a population-based longitudinal study in the Brazilian Amazon and investigated whether these effects were modified by vitaminDstatus,a well-established correlate of BMI. They found that the A allele of FTOSNP rs9939609 was associated with significantly higher BMI gain during childhood. Moreover, the effect of the A allele was significantly stronger in individuals with insufficient concentrations of vitamin D in their blood (<75 nmol/L) and nearly absent in those with sufficient vitamin D. In other words, having adequate vitamin D negated the effect of the FTO risk allele. This relationship is conceptually similar to that seen in a meta-analysis of 218,166 adults where the effect of the rs9939609 A allele was stronger in individuals with another risk factor for obesity, physical inactivity, but weaker in those who were physically active (7).
Lourenco et al. (6) has several strengths. Most important are the longitudinal study design, with up to three study visits 2-3 years apart, and the direct measurement of BMI and serum vitamin D. Additionally, conducting the study in children with a mean age of 5 years at the baseline visit is important because this is the period when individuals start to become overweight (versus adolescence or adulthood). This would also be an opportune age to intervene with behavioral modifications, such as increasing vitamin D intake and/or physical activity, before an individual becomes overweight. One weakness of the study is that information on physical activity was not collected. As physical activity is associated with both BMI and vitamin D (through sun exposure), the interaction seen with vitamin D status could actually reflect an interaction with physical activity instead of vitamin D. This issue should be addressed by future studies.
Vitamin D supplementation
Figure 1—Vitamin D supplementation to remove obesity risk due to the FTO gene.
If the results of this study were replicated, they would have important clinical practice and public health implications because raising children's vitamin D concentrations to at least 75 nmol/L would remove the risk due to the FTO gene (Fig. 1). Vitamin D supplementation is inexpensive ($5-10 per month in the U.S.) and easy (most kids love the chewable fruit-flavored supplements) compared with most behavioral interventions for reducing obesity.
The role that gene-environment interactions play in health and disease has been largely overlooked. However, great promise for personalized medicine lies in uncovering these interactions because while one's genetic risk is not modifiable, behavioral factors are. Health care providers could use genetic information to personalize behavioral interventions. Pharmacogenomic panels are being developed and used in clinical laboratories and genomic information is increasingly included in electronic medical records to aid in clinical decision-making (8). To date, the decisions have involved pharmacologic treatment, particularly for cancer, but behavioral recommendations could also be tailored to individual patients. This holds promise for the prevention of obesity, type 2 diabetes, hypertension, and coronary heart disease in the future.
Duality of Interest. No potential conflicts of interest relevant to this article were reported.
- 1. de Onis M, Blossner M, Borghi E. Global prevalence and trends of overweight and obesity among preschool children. Am J Clin Nutr 2010;92: 1257-1264
- 2. Park MH, Falconer C, Viner RM, Kinra S. The impact of childhood obesity on morbidity and mortality in adulthood: a systematic review. Obes Rev 2012; 13:985-1000
- 3. World Health Organization. Obesity and Overweight Fact Sheet. Geneva, Switzerland, 2013
- 4. Department of Health and Human Services. The Surgeon General's Call to Action to Prevent and Decrease Overweight and Obesity. Washington, DC, U.S. Govt. Printing Office, 2001
- 5. Department of Health and Human Services. With Understanding and Improving Health and Objectives for Improving Health. Washington, DC, U.S. Govt. Printing Office, 2000
- 6. Lourengo BH, Qi L, Willett WC, Cardoso MA; ACTION Study Team. FTO genotype, vitamin D status, and weight gain during childhood. Diabetes 2014;63:808-814
- 7. Kilpelainen TO, Qi L, Brage S, et al. Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children. PLoS Med 2011;8:e1001116
- 8. Manolio TA, Chisholm RL, Ozenberger B, et al. Implementing genomic medicine in the clinic: the future is here. Genet Med 2013;15:258-267
Diabetes February 2014 vol. 63 no. 2 808-814
Barbara H. Lourenço 1,
Lu Qi 2,
Walter C. Willett 2 and
Marly A. Cardoso 3⇑
for the ACTION Study Team Marly A. Cardoso, firstname.lastname@example.org.
1Public Health Nutrition Program, School of Public Health, University of São Paulo, São Paulo, Brazil
2Department of Nutrition, Harvard School of Public Health, Boston, MA
3Department of Nutrition, School of Public Health, University of São Paulo, São Paulo, Brazil
Previous evidence suggests that variants in the fat mass and obesity-associated gene (FTO) affect adiposity in an age-dependent fashion in children, and nutritional factors may modify genotype effects. We assessed the effect of FTO rs9939609 on BMI and BMI-for-age Z score changes during childhood in a population-based longitudinal study in the Brazilian Amazon and investigated whether these effects were modified by vitamin D status, an important nutritional factor related to adiposity. At baseline, 1,088 children aged <10 years had complete genotypic and anthropometric data; 796 were followed up over a median 4.6 years. Baseline vitamin D insufficiency was defined as <75 nmol/L. We observed a 0.07 kg/m2/year increase in BMI and a 0.03 Z/year increase in BMI-for-age Z score per rs9939609 risk allele over follow-up (P = 0.01). Vitamin D status significantly modified FTO effects (P for interaction = 0.02). The rs9939609 risk allele was associated with a 0.05 Z/year increase in BMI-for-age Z score among vitamin D–insufficient children (P = 0.003), while no significant genetic effects were observed among vitamin D–sufficient children. Our data suggest that FTO rs9939609 affects child weight gain, and genotype effects are more pronounced among children with insufficient vitamin D levels.
- Overview Obesity and Vitamin D
- Search PubMed for Obesity and “vitamin d” 1120 items Jan 2014
- Those low on vitamin D were 2.4X more likely to gain weight – June 2013
- Obese need 2.5 IU of vitamin D per kg to increase 1 ng (about 3.4 X more) – RCT Sept 2013
- Vitamin D roles in obesity: genetics and cell signaling – June 2013
- Cross-Sectional and Prospective Cohort Study The HUNT Study Feb 2012
has the following chart ( PDF is attached at the bottom of this page)
- Clinical trials of Obese or Overweight and Vitamin D INTERVENTION 81 trials listed as of Jan 2014
- Life-Course Analysis of a Fat Mass and Obesity-Associated (FTO) Gene Variant and Body Mass Index in the Northern Finland Birth Cohort 1966 Using Structural Equation Modeling
has the following chart, (Shading added by VitaminDWiki) PDF is attached at the bottom of this page
- How you CAN beat your 'fat genes' and lose weight... with exercise DailyMail 2011
In couch-potatoes with one copy of the gene, odds of obesity were 30 per cent higher than in those who do not have it.
In those who exercised, the gene only raised the odds 22 per cent.
Some 49% of Britons have one flawed copy of the FTO gene.
Another 14% have two flawed FTO genes
+ those who did not exercise had a 69% higher chance of obesity than those without the gene.
+The figure fell by 29 per cent in those who exercised.
- SNPwatch: Association Between FTO Variant and Obesity Depends on Age and Impacts Development 23andME has many articles on FTO gene
the $99 DNA testing is not available currently (Jan 2014), but you could just take lots of vitamin D and see if you have one or two FTO gene problems